Log In to Register
When and Where
  • 12/2/2021 3:00 PM EST
  • 12/2/2021 4:00 PM EST
  • This meeting is being held virtually
Event Banner

Primary treatment for VTE, manifesting as deep-vein thrombosis (DVT) and pulmonary embolism (PE), continues for 3–6 months, and secondary prevention may be indicated thereafter. Ensuring that the treatment plan is carried out across the multiple transitions of care that patients with VTE often experience is crucial to avoid hospital admission or readmission. This session will feature an AMGA member panel where leaders in transitions of care will share their strategies to better manage transitions of care for patients with VTE in both inpatient and outpatient settings.